Han-yuan Zheng,Yu-dun Liu,Y.J. Zhang,Qinghua Shi,Xue-li Hou,Lin An
出处
期刊:New Journal of Chemistry [The Royal Society of Chemistry] 日期:2023-12-06卷期号:48 (3): 1241-1247被引量:2
标识
DOI:10.1039/d3nj03289b
摘要
To decrease the potential side effects of the quinoline alkaloid camptothecin (CPT) in the treatment of malignant tumors, a supramolecular drug delivery based on synthesized biotin–PEG-linked calix[4]arene (PDCA) has been successfully developed.